Generic Sinemet Controlled-Release is used for treating symptoms associated with Parkinson disease and parkinsonism-like symptoms caused by other conditions.
Depomed begins Phase II Parkinson's disease trial - Pharmaceutical Business Review
Depomed begins Phase II Parkinson's disease trialPharmaceutical Business ReviewDepomed has commenced a Phase II trial of DM-1992, a gastric-retentive, extended-release formulation of carbidopa/levodopa, in patients with advanced Parkinson's disease with motor fluctuations.
Depomed Announces Initiation of Phase 2 Clinical Study in Parkinson's Disease - VAdvert Press Center (press release)
Depomed Announces Initiation of Phase 2 Clinical Study in Parkinson's DiseaseVAdvert Press Center (press release)Depomed, Inc.
Huntington's Disease: Symptoms and Treatments of a Deadly Condition - International Business Times
International Business TimesHuntington's Disease: Symptoms and Treatments of a Deadly ConditionInternational Business TimesFor more twisted-looking stiff muscles, Anticholinergic agents (Trihexyphenidyl, Benztropine), Carbidopa-levodopa, Dopamine agonists (Pramipexole, Ropinirole) and a Botulinum toxin (Botox) injection can be used.
Impax nabs AstraZeneca migraine drug, will hire 20 people - Bizjournals.com (blog)
Impax nabs AstraZeneca migraine drug, will hire 20 peopleBizjournals.
DOTW Spies the Brandification of Generics - The IN VIVO Blog (blog)
The IN VIVO Blog (blog)DOTW Spies the Brandification of GenericsThe IN VIVO Blog (blog)Zomig will keep the firm's contract sales force occupied once the Lyrica co-promote expires in June while the company awaits word from FDA on an NDA for IPX066, an extended release formulation of carbidopa-levodopa for Parkinson's disease.